Brief: PYC Therapeutics Says Submitted IND Application With U.S. FDA For VP-001
02/02/2023 24:38
Feb 2 (Reuters) - PYC Therapeutics Ltd PYC.AX :
* SUBMISSION OF IND APPLICATION WITH U.S. FDA IN SUPPORT OF
VP-001
Source text for Eikon: ID:nASXRswRj
Further company coverage: PYC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PYC Therapeutics
See all newsAustralia's PYC Therapeutics rises on EU orphan drug status
Brief: PYC Therapeutics Posts HY Revenues From Ordinary Activities A$11.0 Million
Brief: PYC Therapeutics Announces Raising Up To A$653 Million
Brief: PYC Therapeutics Seeks Trading Halt
Brief: PYC Therapeutics Says Rohan Hockings Re-Appointed As Managing Director